reports
BriaCell Therapeutics Announces Closing of $5.0 Million Registered Dir...
BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering PHILADELPHIA and VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, today announced it has closed its previously announced registered direct offering with healthcare-focused institutional investors and a certain existing investor and a director of the Company for the purchase and sale of 2,402,935 common sh...
DBV Technologies annonce son intention de modifier le ratio d'ADS
DBV Technologies annonce son intention de modifier le ratio d'ADS Châtillon, France, le 17 mai 2024 DBV Technologies annonce son intention de modifier le ratio d'ADS DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT—CUSIP: 23306J101), une société biopharmaceutique au stade clinique spécialisée dans les options de traitement des allergies alimentaires et d'autres conditions immunologiques dont les besoins médicaux ne sont pas satisfaits (« la Société »), a annoncé aujourd'hui son intention de modifier le ratio de ses American Depositary Shares ("ADS") par ra...
Ault Alliance Declares Monthly Cash Dividend of $0.2708333 Per Share o...
LAS VEGAS--(BUSINESS WIRE)-- (NYSE American: AULT), a diversified holding company (“Ault Alliance,” or the “Company”), today announced that its Board of Directors has declared a monthly cash dividend of $0.2708333 per share of the Company’s outstanding 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock. The record date for this dividend is May 31, 2024, and the payment date is Monday, June 10, 2024. Link to NYSE quote for the Company’s 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock: For more information on Ault Alliance and its subsidiaries, Ault Alliance re...
DBV Technologies Announces Plan to Implement ADS Ratio Change
DBV Technologies Announces Plan to Implement ADS Ratio Change Châtillon, France, May 17, 2024 DBV Technologies Announces Plan to Implement ADS Ratio Change DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT—CUSIP: 23306J101), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today announced plans to change the ratio of its American Depositary Shares (“ADSs”) to its ordinary shares (the “ADS Ratio”), nominal value €0.10 (ten cents) per share, from the...
Primech Holdings Limited Announces Receipt of Nasdaq Notification Lett...
Primech Holdings Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency SINGAPORE, May 17, 2024 (GLOBE NEWSWIRE) -- Primech Holdings Limited (Nasdaq: PMEC) ("Primech" or the "Company"), an established technology-driven facilities services provider in the public and private sectors operating mainly in Singapore, today announces that it received a delinquency notification letter (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on May 14, 2024 indicating that the Company is not currently in complian...
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(...
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) NOVATO, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 17,180 restricted stock units of the company’s common stock to ten newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan,...
Nuvini (Nasdaq: NVNI) Announces Nasdaq Notification of Non-Compliance ...
Nuvini (Nasdaq: NVNI) Announces Nasdaq Notification of Non-Compliance Regarding Delayed Form 20-F Filing NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- Nvni Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), the leading serial acquirer of private SaaS B2B companies in Latin America, announced that it received a notice of non-compliance (the “Notice”) from the Nasdaq Stock Market (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) because the Company did not timely file its annual report for the fiscal year ended December 31, 2023 on Form 20-F (t...
DZS Inc. Receives Expected Nasdaq Notice Regarding Late Form 10-Q Fili...
DZS Inc. Receives Expected Nasdaq Notice Regarding Late Form 10-Q Filing DALLAS, May 17, 2024 (GLOBE NEWSWIRE) -- (“DZS” or the “Company”) (Nasdaq: DZSI), a global leader of broadband networking and software-defined cloud solutions, announced today that on May 14, 2024, as expected, it received a delinquency notification letter from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with the continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”) because the Company did not timely file its Quarterly Report on Form 10-Q for the...
Entegris Inc: 1 director
A director at Entegris Inc sold 1,986 shares at 133.840USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Moody's Ratings affirms A1/VMIG 1 of The Health, Educational and Housi...
Moody's Ratings ("Moody's") has affirmed A1/VMIG 1 rating assigned to The Health, Educational and Housing Facility Board of the County of Shelby, Tennessee Variable Rate Revenue Bonds, Series 2008A (Methodist Le Bonheur Healthcare) ("Series 2008A") and Variable Rate Revenue Bonds, Series 2008B (Meth...
Xylem Inc. Declares Second Quarter Dividend of 36 Cents per Share
WASHINGTON--(BUSINESS WIRE)-- The Board of Directors of Xylem Inc. (NYSE: XYL), has declared a second quarter dividend of $0.36 per share payable on June 27, 2024, to shareholders of record as of May 30, 2024. About Xylem Xylem (XYL) is a leading global water technology company committed to solving the world’s critical water challenges with innovation and expertise. Our 23,000 diverse employees delivered combined pro forma revenue of $8.1 billion in 2023. We are creating a more sustainable world by enabling our customers to optimize water and resource management and helping communities in ...
- Tian Hou
BZ: Positive On 1Q24 Performance, Supported By Listings Growth In Serv...
We are positive about BZ’s performance in 1Q24. Due to the natural recovery of China’s underlying domestic economy and State economic stimulus, the job market has shown some improvements since 4Q23. The number of total paid job listings on the platform is likely to be up 6.7% Y/Y in 1Q24. As the policy front is becoming more pro-business, we believe BZ is likely to benefit as a result.
- Tian Hou
PDD: Positive On 1Q24 Performance Driven By Rapid Growth From Temu
We are positive about PDD’s performance in 1Q24 driven by Temu. TEMU’s contribution continues to be significant, as it not only contributes to topline growth, but also to the margins. We estimate that TEMU likely contributes approximately 30% of GMV to PDD’s revenue. We estimate GMV Q/Q growth to be ~18.5% in 1Q24, with approximately two-thirds of GMV coming from the US market.
OceanPal Inc. Announces Results of 2024 Annual Meeting of Shareholders
OceanPal Inc. Announces Results of 2024 Annual Meeting of Shareholders ATHENS, Greece, May 17, 2024 (GLOBE NEWSWIRE) -- OceanPal Inc. (NASDAQ: OP) (the “Company”), a global shipping company specializing in the ownership of vessels, today announced that the Company’s Annual Meeting of Shareholders (the “Meeting”) was duly held on May 17, 2024, in virtual format only via the Internet. At the Meeting, each of the following proposals, which are set forth in more detail in the Notice of Annual Meeting of Shareholders and the Company’s Proxy Statement sent to shareholders on or around April ...
Virios Therapeutics Announces Proposed Public Offering of Common Stock...
Virios Therapeutics Announces Proposed Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study ATLANTA, May 17, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“FM”) and Long-COVID (“LC”), today announced that it intends to offer and sell up to $2.1 million in shares of its common stock in a public offering. All shares of common stock ...
Monday.Com Ltd: 1 director
A director at Monday.Com Ltd sold 27,800 shares at 220.720USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
VusionGroup: 1 director
A director at VusionGroup sold 15,000 shares at 158.198EUR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
DTE Energy Co: 1 director
A director at DTE Energy Co sold 10,000 shares at 116.000USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
Packaging Corp of America: 1 director
A director at Packaging Corp of America bought 300 shares at 182.060USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
Safe Bulkers Inc: 1 director
A director at Safe Bulkers Inc sold 15,531 shares at 5.476USD and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.